{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:05:11Z","timestamp":1793225111902,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"MRC Centre","award":["G1002033"],"award-info":[{"award-number":["G1002033"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Early Human Development"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.earlhumdev.2018.09.002","type":"journal-article","created":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T01:20:26Z","timestamp":1537233626000},"page":"18-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Selective or universal screening for GBS in pregnancy (review)"],"prefix":"10.1016","volume":"126","author":[{"given":"Andrew P.","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona C.","family":"Denison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0005","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1093\/cid\/cix656","article-title":"Infant group B streptococcal disease incidence and serotypes worldwide: systematic review and meta-analyses","volume":"65","author":"Madrid","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0010","doi-asserted-by":"crossref","first-page":"A2","DOI":"10.1136\/archdischild-2016-310863.3","article-title":"Group B streptococcal (GBS) disease in UK and Irish infants younger than 90\u202fdays, 2014\u20132015","volume":"101","author":"O'Sullivan","year":"2016","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0015","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1258\/0969141053908366","article-title":"The prevention of neonatal group B streptococcal disease: a report by a working group of the medical screening society","volume":"12","author":"Law","year":"2005","journal-title":"J. Med. Screen."},{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0020","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJM198606263142603","article-title":"Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis","volume":"314","author":"Boyer","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0028-2243(91)90045-M","article-title":"Intrapartum chemoprophylaxis of early-onset group B streptococcal disease","volume":"40","author":"Matorras","year":"1991","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"RR-10","key":"10.1016\/j.earlhumdev.2018.09.002_bb0030","first-page":"1","article-title":"Prevention of perinatal group B streptococcal disease: revised guidelines from CDC, 2010","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR"},{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0035","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1093\/cid\/cix654","article-title":"Intrapartum antibiotic chemoprophylaxis policies for the prevention of group B streptococcal disease worldwide: systematic review","volume":"65","author":"Le Doare","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0040","series-title":"Prevention of neonatal group B streptococcal disease in the Netherlands [Preventie van neonatale groep-B-streptokokkenziekte] version 2.0","author":"Nederlandse vereniging voor obstetrie en gynaecologie","year":"2012"},{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0045","first-page":"e280","article-title":"Prevention of early-onset neonatal group B streptococcal disease. Green-top guideline no. 36","volume":"124","author":"Hughes","year":"2017","journal-title":"BJOG"},{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0050","series-title":"Audit of Current Practice in Preventing Early-onset Neonatal Group B Streptococcal Disease in the UK. First Report","author":"Royal College of Obstetricians and Gynaecologists","year":"2015"},{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0055","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3109\/14767058.2014.934804","article-title":"Intrapartum GBS screening and antibiotic prophylaxis: a European consensus conference","volume":"28","author":"Di Renzo","year":"2015","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0060","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12884-017-1432-3","article-title":"Adverse events in women and children who have received intrapartum antibiotic prophylaxis treatment: a systematic review","volume":"17","author":"Seedat","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0065","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1111\/1471-0528.12371","article-title":"Are we using too many antibiotics during pregnancy? A commentary","volume":"120","author":"Ledger","year":"2013","journal-title":"BJOG"},{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0070","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0140-6736(92)90393-H","article-title":"Prevention of excess neonatal morbidity associated with group B streptococci by vaginal chlorhexidine disinfection during labour. The Swedish chlorhexidine study group","volume":"340","author":"Burman","year":"1992","journal-title":"Lancet"},{"issue":"Issue 12","key":"10.1016\/j.earlhumdev.2018.09.002_bb0075","article-title":"Vaginal chlorhexidine during labour to prevent early-onset neonatal group B streptococcal infection","author":"Ohlsson","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0080","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1016\/j.vaccine.2015.12.072","article-title":"Status of vaccine research and development of vaccines for GBS","volume":"34","author":"Heath","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0085","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/cid\/cit337","article-title":"Emerging trends in the epidemiology of invasive group B streptococcal disease in England and Wales, 1991\u20132010","volume":"57","author":"Lamagni","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0090","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1093\/cid\/cix658","article-title":"Maternal colonization with group B streptococcus and serotype distribution worldwide: systematic review and meta-analyses","volume":"65","author":"Russell","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0095","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.earlhumdev.2007.01.004","article-title":"An overview of the natural history of early onset group B streptococcal disease in the UK","volume":"83","author":"Colbourn","year":"2007","journal-title":"Early Hum. Dev."},{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0100","first-page":"283","article-title":"Risk factors for group B streptococcus colonisation and disease in Gambian women and their infants","volume":"72","author":"Le Doare","year":"2016","journal-title":"J. Inf. Secur."},{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0105","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1093\/cid\/cix655","article-title":"Risk of early-onset neonatal group B streptococcal disease with maternal colonization worldwide: systematic review and meta-analyses","volume":"65","author":"Russell","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0110","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa020205","article-title":"A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates","volume":"347","author":"Schrag","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0115","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-2013","article-title":"Epidemiology of invasive early-onset neonatal sepsis, 2005 to 2014","volume":"138","author":"Schrag","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0120","article-title":"Long-term outcomes after group B streptococcus infection: a cohort study","author":"Yeo","year":"2018","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0125","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S1473-3099(14)70919-3","article-title":"Incidence of invasive group B streptococcal disease and pathogen genotype distribution in newborn babies in the Netherlands over 25\u202fyears: a nationwide surveillance study","volume":"14","author":"Bekker","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0130","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/AOG.0b013e318280d4f6","article-title":"Effectiveness of intrapartum antibiotic prophylaxis for prevention of early-onset group B streptococcal disease","volume":"121","author":"Fairlie","year":"2013","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0135","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/1471-0528.15041","article-title":"The incidence, characteristics, management and outcomes of anaphylaxis in pregnancy: a population-based descriptive study","volume":"125","author":"McCall","year":"2018","journal-title":"BJOG"},{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0140","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000265942","article-title":"Timing of group B streptococcus screening in pregnancy: a systematic review","volume":"69","author":"Valkenburg-van den Berg","year":"2010","journal-title":"Gynecol. Obstet. Investig."},{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0145","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1056\/NEJMoa0806820","article-title":"Evaluation of universal antenatal screening for group B streptococcus","volume":"360","author":"Van Dyke","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0150","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJM200007203430303","article-title":"Rapid detection of group B streptococci in pregnant women at delivery","volume":"343","author":"Bergeron","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0155","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1471-0528.2010.02725.x","article-title":"Intrapartum tests for group B streptococcus: accuracy and acceptability of screening","volume":"118","author":"Daniels","year":"2011","journal-title":"BJOG"},{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0160","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/AOG.0b013e31824b1461","article-title":"Cost and effectiveness of intrapartum group B streptococcus polymerase chain reaction screening for term deliveries","volume":"119","author":"El-Helali","year":"2012","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0165","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/1471-0528.12841","article-title":"Prevention of early-onset group B streptococcal disease \u2013 the Northern Ireland experience","volume":"122","author":"Eastwood","year":"2015","journal-title":"BJOG"},{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0170","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/ije\/dyh062","article-title":"Prenatal screening for group B streptococcal infection: gaps in the evidence","volume":"33","author":"Gilbert","year":"2003","journal-title":"Int. J. Epidemiol."},{"issue":"Issue 6","key":"10.1016\/j.earlhumdev.2018.09.002_bb0175","article-title":"Intrapartum antibiotics for known maternal group B streptococcal colonization","author":"Ohlsson","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0180","series-title":"UK NSC Group B Streptococcus (GBS) Recommendation","author":"UK National Screening Committee","year":"2017"},{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0185","series-title":"HTA 17\/86","article-title":"The clinical and cost effectiveness of screening for Group B Streptococcus (GBS) in pregnancy","author":"National Institute for Health Research Health Technology Assessment Programme","year":"2017"},{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0190","series-title":"Standards for Maternal and Neonatal Care","first-page":"2006","article-title":"Maternal immunization against tetanus","author":"World Health Organization","year":"2006"},{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0195","author":"Public Health England"},{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0200","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJM197604012941404","article-title":"Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection","volume":"294","author":"Baker","year":"1976","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.earlhumdev.2018.09.002_bb0205","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S1473-3099(16)00152-3","article-title":"Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in health women and their infants: a randomised phase 1b\/2 trial","volume":"16","author":"Madhi","year":"2016","journal-title":"Lancet Infect. Dis."}],"container-title":["Early Human Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378378218305723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378378218305723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T01:56:34Z","timestamp":1759888594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378378218305723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":41,"alternative-id":["S0378378218305723"],"URL":"https:\/\/doi.org\/10.1016\/j.earlhumdev.2018.09.002","relation":{},"ISSN":["0378-3782"],"issn-type":[{"value":"0378-3782","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective or universal screening for GBS in pregnancy (review)","name":"articletitle","label":"Article Title"},{"value":"Early Human Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.earlhumdev.2018.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}